Showing results (61-70 of 229) with videos related to

Sort By:
Pageof 23
Neurourology and Urodynamics|February 14, 2016
Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014Apostolos Apostolidis, Mohammad S Rahnama'i, Christopher Fry, et al.
American Journal of Obstetrics and Gynecology|December 26, 2002
The use of intraoperative cystoscopy in major vaginal and urogynecologic surgeriesChristina H Kwon, Roger P Goldberg, Sumana Koduri, et al.
European Urology|November 14, 2006
Efficacy and tolerability of tolterodine extended release in male and female patients with overactive bladderRoger Dmochowski, Paul Abrams, Daniela Marschall-Kehrel, et al.
The Journal of Urology|April 12, 2005
The overactive bladder-symptom composite score: a composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladderNorman Zinner, Mark Harnett, Luann Sabounjian, et al.
Urology|March 22, 2020
Use of Botulinum Toxin A (BoNT-A) in Detrusor External Sphincter Dyssynergia (DESD): A Systematic Review and Meta-analysisShokhi Goel, Hudson Pierce, Kevin Pain, et al.
World Journal of Urology|August 22, 2019
Can men with lower urinary tract symptoms (LUTs) predict voided volumes?Mitali Kini, Dominique Thomas, Nadir Zaidi, et al.
The Journal of Urology|December 14, 2012
Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trialRoger Dmochowski, Claus Roehrborn, Suzanne Klise, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|April 19, 2005
Successful treatment of Zoon's vulvitis with high potency topical steroidSylvia M Botros, Mark Dieterich, Peter K Sand, et al.
International Urogynecology Journal|August 9, 2011
Can pelvic floor injury secondary to delivery be prevented?Yuval Lavy, Peter K Sand, Chava I Kaniel, et al.
International Urology and Nephrology|March 3, 2007
Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trialsRobert B Armstrong, Roger R Dmochowski, Peter K Sand, et al.
Pageof 23